SEC Filings for Actinium Pharmaceuticals Inc. (Delaware) (ATNM)

$ 0.203   0.0024 (+1.20%) Volume: 928.16k 2:48 PM EDT 31-Mar-2020
Filing Type:
Form TypeForm DescriptionPagesDateView
8-KCurrent report pursuant to Section 13 or 15(d)303/27/2020
SC 13G/A[Amend] Statement of acquisition of beneficial ownership by individuals1802/14/2020
SC 13G/A[Amend] Statement of acquisition of beneficial ownership by individuals101/08/2020
8-KCurrent report pursuant to Section 13 or 15(d)412/19/2019
8-KCurrent report pursuant to Section 13 or 15(d)312/03/2019
8-KCurrent report pursuant to Section 13 or 15(d)311/25/2019
DEF 14AOther definitive proxy statements7611/25/2019
PRE 14APreliminary proxy statement providing notification matters to be brought to a vote5511/15/2019
10-QGeneral form for quarterly reports under Section 13 or 15(d)4911/12/2019
SC 13GStatement of acquisition of beneficial ownership by individuals1610/31/2019
10-QGeneral form for quarterly reports under Section 13 or 15(d)4608/09/2019
4Statement of changes in beneficial ownership of securities107/16/2019
4Statement of changes in beneficial ownership of securities107/16/2019
4Statement of changes in beneficial ownership of securities107/16/2019
4Statement of changes in beneficial ownership of securities107/16/2019
<<
First
<
Prev
123456789101112131415